TEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Teva Pharmaceutical Industries Ltd's other long-term assets for the quarter that ended in Jun. 2014 was $1,469 Mil.
Teva Pharmaceutical Industries Ltd's quarterly other long-term assets declined from Dec. 2013 ($1,696 Mil) to Mar. 2014 ($1,470 Mil) and declined from Mar. 2014 ($1,470 Mil) to Jun. 2014 ($1,469 Mil).
Teva Pharmaceutical Industries Ltd's annual other long-term assets increased from Dec. 2011 ($1,133 Mil) to Dec. 2012 ($1,338 Mil) and increased from Dec. 2012 ($1,338 Mil) to Dec. 2013 ($1,696 Mil).
Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.
A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Teva Pharmaceutical Industries Ltd Annual Data
|Other Long-Term Assets||843||410||613||712||901||676||770||1,133||1,338||1,696|
Teva Pharmaceutical Industries Ltd Quarterly Data
|Other Long-Term Assets||1,207||1,227||1,356||1,338||1,385||1,399||1,532||1,696||1,470||1,469|